HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder.

Abstract
The regional cerebral effects of an anxiolytic (clorazepate) in 20 patients with generalized anxiety disorder were assessed using 16-channel electroencephalogram (EEG) power spectral estimate maps of the left hemisphere. Patients were studied with double-blind random assignment to placebo or drug and were assessed at baseline, day 7, and day 14 with EEG and Hamilton Anxiety Ratings. Ten age- and sex-matched normal controls were also tested. Hamilton Anxiety Ratings were decreased significantly more in the drug group than in the placebo group. Topographic maps of EEG activity revealed decreases in occipital alpha and parietal delta, together with increases in posterior frontal (central EEG leads) and parietal beta. Decreases in delta are consistent with a lack of sedation; the reciprocal beta increases in parietal cortex are similarly consistent. This pattern of regional EEG changes in the direction of alert attentiveness, together with individual differences, observed in frontal/parietal and occipital alpha activity, suggests the importance of at least these two cortical regions for anxiolytic action. Differences between patients with generalized anxiety disorder and normals were restricted to the occipital and temporal regions. These results suggest the importance of multilead recording in assessing EEG correlates of drug action.
AuthorsM S Buchsbaum, E Hazlett, N Sicotte, M Stein, J Wu, M Zetin
JournalBiological psychiatry (Biol Psychiatry) Vol. 20 Issue 8 Pg. 832-42 (Aug 1985) ISSN: 0006-3223 [Print] United States
PMID2862924 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Anxiety Agents
  • Clorazepate Dipotassium
Topics
  • Adult
  • Anti-Anxiety Agents (therapeutic use)
  • Anxiety Disorders (drug therapy, physiopathology)
  • Clorazepate Dipotassium (therapeutic use)
  • Electroencephalography
  • Female
  • Humans
  • Individuality
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: